Abstract
Background Evidence from observational studies suggests an association between mental disorders and cancers. However, the causality of this association remains unclear.
Methods We collected genome-wide association study (GWAS) summary statistics of five mental disorders from the Psychiatric Genomics Consortium (PGC, 72,517 to 500,199 participants), paired with GWAS summary statistics of the risks of 18 cancer types from the UK Biobank (167,020 to 361,194 participants) and FinnGen database (110,521 to 264,701 participants). We conducted univariable and multivariable Mendelian randomization (MR) analyses to explore the causal relationships.
Results We identified ten causal associations between mental disorders and cancer risks. Notably, anorexia nervosa (AN) exhibits a causal association with a decreased risk of prostate cancer (β = -0.30, p = 1.61 × 10-6) and an elevated risk for stomach cancer (β = 0.47, p = 5.3 × 10-3). Bipolar disorder (BD) is causally linked to a reduced risk of pancreatic cancer (β = -5.13 × 10-4, p = 3.2 × 10-3). Major depression disorder (MDD) is causally associated with an elevated risk of bladder cancer (β = 1.84 × 10-3, p = 5.0 × 10-4) and kidney cancer (β = 1.40 × 10-3, p = 4.9 × 10-3). Additionally, we found the causal effect of skin melanoma on BD (β = -10.39, p = 2.1×10-4) and Schizophrenia (SCZ, β = -7.42, p = 3.3 × 10-4) with a bi-directional MR analysis. Moreover, we identified leukocyte count as a causal mediator of a causal association between AN and stomach cancer with a two-step MR analysis.
Conclusions In summary, our MR analysis reveals that mental disorders were causally associated with cancer risks.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The mental disorder GWAS summaries were downloaded from the PGC website (https://pgc.unc.edu/for-researchers/download-results/). The GWAS summary from UK Biobank were downloaded from the Neala Lab (http://www.nealelab.is/uk-biobank). The GWAS summary from FinnGen were downloaded following the instruction on its website (https://www.finngen.fi/en/access_results).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Abbreviations
- ADHD
- Attention-deficit and hyperactivity disorder
- AN
- Anorexia nervosa
- BD
- Bipolar disorder
- GWAS
- Genome-wide association study
- HDL
- High-density lipoprotein
- IV
- Instrument variable
- IVW
- Inverse variance weighted
- MDD
- Major depression disorder
- MR
- Mendelian randomization
- MRE
- MR-Egger
- MVMR
- Mendelian randomization
- SCZ
- Schizophrenia
- SM
- Simple mode
- SNP
- Single-nucleotide polymorphisms
- UVMR
- Univariate Mendelian randomization
- WM
- weighted median
